Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis.
Antimicrob Agents Chemother
; 60(1): 662-5, 2016 01.
Article
en En
| MEDLINE
| ID: mdl-26525799
ABSTRACT
Treatment of Candida glabrata cystitis remains a therapeutic challenge, and an antifungal combination using flucytosine is one option. We describe two patients with refractory C. glabrata cystitis who failed flucytosine combined with caspofungin with early-acquired high-level resistance to flucytosine due to nonsense mutations in the FUR1 gene. Rapidly acquired flucytosine resistance with microbiological failure should discourage combination of caspofungin and flucytosine during urinary candidiasis.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Candidiasis
/
Cistitis
/
Farmacorresistencia Fúngica
/
Candida glabrata
/
Equinocandinas
/
Lipopéptidos
/
Flucitosina
/
Antifúngicos
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Antimicrob Agents Chemother
Año:
2016
Tipo del documento:
Article
País de afiliación:
Francia